Foghorn Therapeutics Inc. Common Stock (FHTX) is a publicly traded Healthcare sector company. As of May 21, 2026, FHTX trades at $4.00 with a market cap of $224.29M and a P/E ratio of -3.34. FHTX moved +11.25% today. Year to date, FHTX is -19.68%; over the trailing twelve months it is -3.38%. Its 52-week range spans $2.94 to $9.99. Analyst consensus is strong buy with an average price target of $11.60. Rallies surfaces FHTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes FHTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $4.00 |
| Market Cap | $224.29M |
| P/E Ratio | -3.34 |
| EPS | $-1.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.99 |
| 52-Week Low | $2.94 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $28.22M |
| Net Income | $-75.32M |
| Gross Margin | 0.00% |
6 analysts cover FHTX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.60.